17 Oktober 2014
BIO Investor Forum closing plenary:
How fragile is the biotech rally after five positive years?
Last week’s 13th Annual BIO Investor Forum closed on Wednesday with a plenary session asking, “How fragile is the biotech…
- Biotechnology Innovation Organization (BIO)
- Dicerna Pharmaceuticals, Inc.
- Forest Laboratories
- MPM Capital
- ROTH Capital Partners
- US Food and Drug Administration (FDA)